The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension
A study for patients with Glaucoma or Ocular Hypertension using study drug Bimatoprost SR
Sponsor: Eisai
Enrolling: Male and Female Patients
IRB Number: AAAP8913
U.S. Govt. ID: NCT02247804
Contact: Edylin M. Bautista: 212-305-5922 / mmb2225@columbia.edu
Additional Study Information: This study is for patients with Glaucoma. The purpose of this study is to investigate the safety and effectiveness of a study drug called Bimatoprost Sustained Release (SR) compared to treatment with eye drug Timolol. The Bimatoprost SR is an implant that is very small, is biodegradable (dissolves naturally in the body), and contains the bimatoprost drug.
This study is closed
Investigator
Lama Al-Aswad, MD, MPH
Do You Qualify?
Do you have Glaucoma? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Edylin M. Bautista
mmb2225@columbia.edu
212-305-5922
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE